1404 related articles for article (PubMed ID: 18245806)
1. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O; Watier L; Rossert J; Stengel B;
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[TBL] [Abstract][Full Text] [Related]
2. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[TBL] [Abstract][Full Text] [Related]
3. The impact of sex in primary glomerulonephritis.
Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
[TBL] [Abstract][Full Text] [Related]
4. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
[TBL] [Abstract][Full Text] [Related]
5. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
6. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
Weber CL; Rose CL; Magil AB
Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
8. Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience.
Chang JH; Kim DK; Kim HW; Park SY; Yoo TH; Kim BS; Kang SW; Choi KH; Han DS; Jeong HJ; Lee HY
Nephrol Dial Transplant; 2009 Aug; 24(8):2406-10. PubMed ID: 19264742
[TBL] [Abstract][Full Text] [Related]
9. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
10. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
Jafar TH; Schmid CH; Stark PC; Toto R; Remuzzi G; Ruggenenti P; Marcantoni C; Becker G; Shahinfar S; De Jong PE; De Zeeuw D; Kamper AL; Strangaard S; Levey AS
Nephrol Dial Transplant; 2003 Oct; 18(10):2047-53. PubMed ID: 13679479
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis.
Kapitsinou PP; Ioannidis JP; Boletis JN; Sotsiou F; Nakopoulou L; Daphnis E; Moutsopoulos HM
Am J Kidney Dis; 2003 Jan; 41(1):29-37. PubMed ID: 12500219
[TBL] [Abstract][Full Text] [Related]
12. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
13. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
Troyanov S; Wall CA; Miller JA; Scholey JW; Cattran DC;
J Am Soc Nephrol; 2005 Apr; 16(4):1061-8. PubMed ID: 15716334
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
15. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoking and progression of IgA nephropathy.
Yamamoto R; Nagasawa Y; Shoji T; Iwatani H; Hamano T; Kawada N; Inoue K; Uehata T; Kaneko T; Okada N; Moriyama T; Horio M; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y
Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735
[TBL] [Abstract][Full Text] [Related]
17. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and predictors for ESRD and mortality in primary GN.
Chou YH; Lien YC; Hu FC; Lin WC; Kao CC; Lai CF; Chiang WC; Lin SL; Tsai TJ; Wu KD; Chen YM
Clin J Am Soc Nephrol; 2012 Sep; 7(9):1401-8. PubMed ID: 22798538
[TBL] [Abstract][Full Text] [Related]
20. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]